OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/15/2026
Back to search
Official data from USPTO
BIOLAMININ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOLAMININ
ST13
US500000079401273Class
1, 5
Filing
79401273
Registration
7691613
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
12
Latest update
01/16/2026
Trademark type
Word
Nice classes
1, 5
Filing date
05/24/2024
Registration date
02/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
01/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
64
Owner location
SE
Examiner
MARTIN,CHRISTINE C
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BioLamina AB
Representatives
BioLamina AB
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cell growth substrate for growing cells for use in scientific research; buffersreagents and other chemicals for use within cell biologicalmolecular biological and biochemical research within academia and industry; protein in raw material form for scientific and medical research; cell culture substrate for laboratory use; cell culture substrate for scientific and research use; natural biomaterial based scaffold to enable two-dimensional and three-dimensional cell culture for research purposes.
Class 5
Culture media for cultivating cells for medical use; biomaterial for making three-dimensional scaffolds for medical purposes; natural biomaterial-based scaffold to enable two-dimensional and three-dimensional cell culture for medical purposes.
Publications
History of USPTO decisions and trademark events.
12 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/31/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/31/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/20/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NPUB
NOTICE OF PUBLICATION
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2024
DOCK
ASSIGNED TO EXAMINER
12/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/01/2024
Continuous trademark protection
Get notified about every new filing that threatens BIOLAMININ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.